A do-over for Medicare Advantage plans members
Of the 26.9 million Medicare beneficiaries enrolled in Medicare Advantage (MA) plans, a percentage of them discovered their plan is
Read More
Part D/Prescription Drugs
A Texas team comes up with a COVID vaccine that could be a global game changer
(By Joe Palca for NPR) A vaccine authorized in December for use in India may help solve one of the
Read MoreUS orders 10 million more courses of Pfizer’s COVID-19 antiviral
(By Erica Carbajal for Becker’s Hospital Review) The U.S. is purchasing an additional 10 million courses of Paxlovid, Pfizer’s COVID-19
Read MoreFDA authorizes Merck’s Covid-19 pill, but stresses its use should be limited
(By Matthew Herper for STAT) The Food and Drug Administration on Thursday granted emergency authorization to Merck’s molnupiravir, an antiviral
Read MoreBehind the Medicare Part B increase
Although Social Security recipients will see the highest cost-of-living adjustment in almost 40 years; however, for Medicare beneficiaries, the raise
Read MoreLocal Pharmacists Fill Rx Void as Big Brands Pull Out of Rural Areas
(By Markian Hawryluk for Kaiser Health News) Bill Mather, a pharmacist in the small Iowa city of Greenfield, wanted to
Read MoreCDC narrows use of J&J vaccine due to concerns about rare blood clots
(By Vanessa Romo and Scott Hensley for NPR) The Centers for Disease Control and Prevention accepted advice from a panel
Read MoreSeeking Refills: Aging Pharmacists Leave Drugstores Vacant in Rural America
(By Markian Hawryluk for Kaiser Health News) Ted Billinger Jr. liked to joke that he would work until he died.
Read MoreAs Aduhelm faces doubts, Biogen plans another pivotal trial for 2022
(By Damian Garde and Adam Feurerstein for STAT) Biogen said Thursday that it expects to begin a large clinical trial
Read MoreWill we always need Covid-19 boosters? Experts have theories
(By Helen Branswell for STAT) With the world facing the latest in a seemingly endless stream of coronavirus variants —
Read More